Aorn Santobono Pausilipon

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Acute lymphoblastic leukaemia1 trial
• Acute myeloid leukaemia1 trial
• Childhood cancers1 trial
• Chronic kidney disease1 trial
• Chronic lymphocytic leukaemia1 trial
• Chronic myeloid leukaemia1 trial

Phase

• Phase 1/21 trial

Status

• Recruiting2 trials

Lead sponsor

• Incyte Biosciences International Sàrl1 trial
• University of Campania Luigi Vanvitelli1 trial

Running trials

• Recruiting

  The PRO-FUTURE Project

  NCT06382233· University of Campania Luigi Vanvitelli· Source

  Contact: Giovanni Di Iorio

• Recruiting

  Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

  NCT03934372· Phase 1/2· Incyte Biosciences International Sàrl· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute lymphoblastic leukaemia1 recruiting
• Acute myeloid leukaemia1 recruiting
• Childhood cancers1 recruiting
• Chronic kidney disease1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Chronic myeloid leukaemia1 recruiting